The niosomal nelarabine as a promising nano combination for retinoblastoma treatment: an in vitro study—experimental research
Nio-Nelarobine may be a functional therapeutic combination for RB treatment. Further experimental and preclinical investigations are necessary to verify this impact in greater detail.
Authors
- Giti Zarinfard (ORCID: https://orcid.org/0000-0001-8127-9194)
- Mitra Soleimani (ORCID: https://orcid.org/0000-0001-7040-3452)
- Maryam Khanehzad (ORCID: https://orcid.org/0000-0001-7191-3745)
- Nafiseh Esmaeil (ORCID: https://orcid.org/0000-0001-7237-1984)
- Mobina Tohidian
- Amir Hossein Naderi Majd
Institutions
- Isfahan University of Medical Sciences (IR)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1097/ms9.0000000000002821
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00